The homeostatic chemokine CCL21 predicts mortality and may play a pathogenic role in heart failure

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Yndestad, Arne ^a,d   Finsen, Alexandraessa Vanessa ^a,b,d   Ueland, Thor ^a,b   Husberg, Cathrine ^c,d   Dahl, Christen P ^a,b,d   Øie, Erik ^a,b,d   Vinge, Leif Erik ^a,b,d   Sjaastad, Ivar ^c,d,e   Sandanger, Øystein ^a,d   Ranheim, Trine ^a   Dickstein, Kenneth ^f,g   Kjekshus, John ^b,d,e   Damås, Jan Kristian ^a   Fiane, Arnt E ^b,e   Hilfiker Kleiner, Denise ^h   Lipp, Martin ⁱ   Gullestad, Lars ^b,d,e   Christensen, Geir ^c,d,e   Aukrust, Pål ^a,b,e  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

^e UNIVERSITY OF OSLO   (Norway)

^f STAVANGER UNIVERSITY HOSPITAL   (Norway)

^g UNIVERSITY OF BERGEN   (Norway)

^h HANNOVER MEDICAL SCHOOL   (Germany)

ⁱ MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; INTERLEUKIN 10; LOSARTAN; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; SECONDARY LYMPHOID TISSUE CHEMOKINE; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1; CCL19 PROTEIN, HUMAN; CCL21 PROTEIN, HUMAN; CCR7 PROTEIN, HUMAN; CHEMOKINE RECEPTOR CCR7;

ACUTE HEART INFARCTION; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DRESSLER SYNDROME; DRUG DOSE TITRATION; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE; HEART MUSCLE; HEART MUSCLE FIBROSIS; HEART STRESS; HEART VENTRICLE HYPERTROPHY; HOMEOSTASIS; HUMAN; HUMAN TISSUE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MOUSE; MYOCARDIAL DISEASE; NONHUMAN; PATHOGENESIS; PREDICTION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; RISK FACTOR; SURVIVAL RATE; ANALYSIS OF VARIANCE; ANIMAL; BLOOD; ENZYME IMMUNOASSAY; GENETICS; HEART INFARCTION; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; MOUSE MUTANT; NORWAY; PATHOPHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

MUS;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANIMALS; CHEMOKINE CCL19; CHEMOKINE CCL21; CROSS-SECTIONAL STUDIES; FEMALE; HEART FAILURE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; LONGITUDINAL STUDIES; MALE; MICE; MICE, KNOCKOUT; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; NORWAY; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CCR7;

EID: 84858013861     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033038     Document Type: Article

References (21)

1. Aukrust P, Gullestad L, Ueland T, Damås JK, Yndestad A, (2005) Inflammatory and anti-inflammatory cytokines in chronic heart failure: potential therapeutic implications. Ann Med 37: 74-85.
2. Mann DL, (2002) Inflammatory Mediators and the Failing Heart: Past, Present, and the Foreseeable Future. Circ Res 91: 988-998.
3. Förster R, Davalos-Misslitz AC, Rot A, (2008) CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol 8: 362-371.
4. Müller G, Höpken UE, Stein H, Lipp M, (2002) Systemic immunoregulatory and pathogenic functions of homeostatic chemokine receptors. J Leukoc Biol 72: 1-8.
5. Menning A, Hopken UE, Siegmund K, Lipp M, Hamann A, et al. (2007) Distinctive role of CCR7 in migration and functional activity of naive- and effector/memory-like Treg subsets. Eur J Immunol 37: 1575-1583.
6. Schneider MA, Meingassner JG, Lipp M, Moore HD, Rot A, (2007) CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells. J Exp Med 204: 735-745.
7. Pierce EM, Carpenter K, Jakubzick C, Kunkel SL, Evanoff H, et al. (2007) Idiopathic pulmonary fibrosis fibroblasts migrate and proliferate to CC chemokine ligand 21. Eur Respir J 29: 1082-1093.
8. Damås JK, Smith C, Øie E, Fevang B, Halvorsen B, et al. (2007) Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis: possible pathogenic role in plaque destabilization. Arterioscler Thromb Vasc Biol 27: 614-620.
9. Kaur D, Saunders R, Berger P, Siddiqui S, Woodman L, et al. (2006) Airway smooth muscle and mast cell-derived CC chemokine ligand 19 mediate airway smooth muscle migration in asthma. Am J Respir Crit Care Med 174: 1179-1188.
10. Dickstein K, Kjekshus J, (2002) Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan. Lancet 360: 752-760.
11. Ueland T, Aukrust P, Yndestad A, Otterdal K, Frøland SS, et al. (2005) Soluble CD40 ligand in acute and chronic heart failure. Eur Heart J 26: 1101-1107.
12. Förster R, Schubel A, Breitfeld D, Kremmer E, Renner-Muller I, et al. (1999) CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99: 23-33.
13. Finsen AV, Christensen G, Sjaastad I, (2005) Echocardiographic parameters discriminating myocardial infarction with pulmonary congestion from myocardial infarction without congestion in the mouse. J Appl Physiol 98: 680-689.
14. Randolph DA, Fathman CG, (2006) Cd4+Cd25+ regulatory T cells and their therapeutic potential. Annu Rev Med 57: 381-402.
15. Bruhl H, Mack M, Niedermeier M, Lochbaum D, Scholmerich J, et al. (2008) Functional expression of the chemokine receptor CCR7 on fibroblast-like synoviocytes. Rheumatology (Oxford) 47: 1771-1774.
16. Kawashima D, Oshitani N, Jinno Y, Watanabe K, Nakamura S, et al. (2005) Augmented expression of secondary lymphoid tissue chemokine and EBI1 ligand chemokine in Crohn's disease. J Clin Pathol 58: 1057-1063.
17. Ait-Oufella H, Salomon BL, Potteaux S, Robertson AK, Gourdy P, et al. (2006) Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med 12: 178-180.
18. Feng G, Chan T, Wood KJ, Bushell A, (2009) Donor reactive regulatory T cells. Curr Opin Organ Transplant 14: 432-438.
19. Kvakan H, Kleinewietfeld M, Qadri F, Park JK, Fischer R, et al. (2009) Regulatory T cells ameliorate angiotensin II-induced cardiac damage. Circulation 119: 2904-2912.
20. Krishnamurthy P, Rajasingh J, Lambers E, Qin G, Losordo DW, et al. (2009) IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR. Circ Res 104: e9-18.
21. O'Garra A, Barrat FJ, Castro AG, Vicari A, Hawrylowicz C, (2008) Strategies for use of IL-10 or its antagonists in human disease. Immunol Rev 223: 114-131.